TELA Bio, Inc.

Contributing Author

Recent Articles by TELA Bio, Inc.

Oct-27	TELA Bio to Announce Third Quarter 2026 Financial Results TELA GlobeNewswire
Oct-05	TELA Bio Announces 510(k) Clearance for Liora Monofilament Scaffold for Soft Tissue Reinforcement TELA GlobeNewswire
Aug-31	TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative TELA +5.43% GlobeNewswire
Aug-10	TELA Bio Reports Second Quarter 2026 Financial Results TELA +6.91% TELA -15.05% GlobeNewswire
Aug-05	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA TELA -6.01% GlobeNewswire
Aug-04	TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director TELA +22.51% GlobeNewswire
Jul-29	TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference TELA GlobeNewswire
Jul-20	TELA Bio to Announce Second Quarter 2026 Financial Results TELA GlobeNewswire
May-12	TELA Bio Reports First Quarter 2026 Financial Results TELA +5.14% TELA -5.88% GlobeNewswire
May-07	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA +11.11% TELA -7.27% GlobeNewswire
Apr-30	TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues TELA TELA +13.07% GlobeNewswire
Apr-21	TELA Bio to Announce First Quarter 2026 Financial Results TELA GlobeNewswire
Mar-24	TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results TELA -8.27% TELA -9.35% GlobeNewswire
Mar-10	TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results TELA TELA -7.35% GlobeNewswire
Feb-20	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA -9.76% TELA +6.77% GlobeNewswire
Jan-23	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA GlobeNewswire
Dec-12	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA GlobeNewswire
Nov-19	TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference TELA -8.47% GlobeNewswire
Nov-17	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA +14.08% GlobeNewswire
Nov-13	TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants TELA TELA -9.97% GlobeNewswire
Nov-13	TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility TELA TELA -9.97% GlobeNewswire
Nov-04	TELA Bio to Announce Third Quarter 2025 Financial Results TELA -5.84% GlobeNewswire
Nov-03	TELA Bio Appoints William Plovanic to Board of Directors TELA +11.38% GlobeNewswire
Oct-09	TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran TELA GlobeNewswire
Aug-11	TELA Bio Reports Second Quarter 2025 Financial Results TELA +8.14% TELA -13.98% GlobeNewswire
Aug-08	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA GlobeNewswire
Jul-23	TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference TELA GlobeNewswire
Jul-21	TELA Bio to Announce Second Quarter 2025 Financial Results TELA -7.04% GlobeNewswire
Jun-06	TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) TELA GlobeNewswire
Jun-03	TELA Bio Announces European Commercial Launch of OviTex Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair TELA +10.56% TELA +19.75% GlobeNewswire
Jun-02	TELA Bio Appoints Jeffrey Blizard as President TELA GlobeNewswire
May-22	TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference TELA GlobeNewswire
May-09	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA +9.04% TELA -6.48% GlobeNewswire
May-08	TELA Bio Reports First Quarter 2025 Financial Results TELA GlobeNewswire

TELA Bio, Inc.

Recent Articles by TELA Bio, Inc.

Upgrade your Finviz experience